PFIZER
|
The Current P/E Ratio of PFIZER is 37.38.
Share Price | ₹4,107.4 | Apr 18,2024 |
Market Cap | ₹18,770.6 Cr | |
Earnings-TTM | ₹502.1 Cr | TTM-Standalone Results |
Price/Earnings | 37.38x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of PFIZER
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹18,770.6 Cr] as on Apr 18,2024
(/) Earnings [ ₹502.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 37.38x ]
Thus, for PFIZER , the investors are currently willing to pay 37.38 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PFIZER !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PFIZER over the last five years.
Historical PE (Price/Earnings) ratio chart of PFIZER
PE Ratio Performance Analysis for PFIZER
- PFIZER 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 34.21x.
- PFIZER 's operated at median p/e ratio of 35.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PFIZER 's p/e ratio peaked in Mar2021 at 41.57x.
- PFIZER 's p/e ratio hit its five-year low in Mar2023 of 25.4x.
How does PFIZER 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
PFIZER | 502.12 | 37.38 | 18,770.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.45 | 364,015.0 |
CIPLA LTD | 3,744.03 | 29.06 | 108,809.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.08 | 99,408.7 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 31.89 | 94,213.7 |
DIVIS LABORATORIES LTD | 1,382.97 | 71.36 | 98,684.0 |
MANKIND PHARMA LTD | 1,743.30 | 55.09 | 96,037.1 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 57.71 | 86,219.0 |
LUPIN LTD | 1,809.74 | 40.13 | 72,621.1 |
AUROBINDO PHARMA LTD | 2,777.89 | 23.52 | 65,326.3 |
ABBOTT INDIA LTD | 1,145.58 | 48.33 | 55,366.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PFIZER 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.08x |
Max industry PE | 71.36x |
Median industry PE | 40.13x |
Average industry PE | 41.27x |
You may also like the below Video Courses